Clinical trial
Early Effect of Cingal® Compared to Monovisc® in Patients With Osteoarthritis of the Knee (EEFFEK Study)
NCT03062787 is registered in ClinicalTrials.gov with Pharmascience Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Effect of Cingal® Compared to Monovisc® in Patients With Osteoarthritis of the Knee (EEFFEK Study)
- Lead sponsor
- Pharmascience Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 5, 2017
- Completion date
- October 25, 2017
- Enrollment
- 60 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.